Labelexpo 2024: Flint to spotlight new ink technology
Flint Group has confirmed its participation in Labelexpo India 2024, scheduled for 14-17 November 2024 at the India Expo Centre & Mart in Noida, Delhi. The Labelexpo show targets label converters and printers from across the region.
25 Oct 2024 | 2100 Views | By Noel D'Cunha
The company will present its latest innovations aimed at enhancing performance in the narrow web sector. Among the key offerings is the EkoCure Dual Cure inks, which can cure under both traditional UV Hg and UV LED lamps. This development allows printers to use a single ink across various presses while transitioning to UV LED curing, minimising the need for extensive ink inventory.
Upal Roy, managing director for India, South Africa, and the Middle East, said, “Technologies like EkoCure provide converters with an asset. This range aids in managing ink inventory while investing in UV LED curing stations. They can transition at their own pace without added complexity. As a result, converters can benefit from lower energy use and waste associated with UV LED curing.”
For those involved in printing for food packaging, Flint Group will highlight Flexocure Ancora, a UV flexo ink that meets industry standards for indirect food contact. This product is intended for diverse applications, including self-adhesive and wrap-around labels.
Flint Group will also showcase Vivo colour solutions, a digital platform that supports tailored colour management processes. This tool allows converters to achieve precise ink formulations based on their specific needs.
Additionally, the company will demonstrate FlintLink, a digital portal that grants customers round-the-clock access to essential documents and data. This platform includes orders, delivery notes, invoices, and more details.
Dr Sreenivas Goud, director for sales narrow web in India and exports, said, “Labelexpo India serves as a hub for innovation. Our team looks forward to connecting with printers at the event to present new ink ranges that support efficiency. We encourage anyone interested to schedule a meeting with our team.”